• Info
  • Significant Ownership

Significant Ownership of Zhenfeng M. Chen

Location
Hong Kong
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Zhenfeng M. Chen.

Follow Filing Activity

Follow Zhenfeng M. Chen and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Significant Ownership of Zhenfeng M. Chen

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CASI CASI Pharmaceuticals, Inc. Ordinary Share 11% $4,150,370 2,255,636 Chen Zhenfeng 30 Sep 2025

Schedules 13D/G Reported by Zhenfeng M. Chen:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.